UCB (MEX:UCBN) Dividend Yield %: 0.00% (As of Jun. 26, 2026)


MEX:UCBN UCB SA MEX:UCBN
85 GF Score
Price MXN1,692.27
GF Value MXN1,417.06
! 2 Warning Signs
View Full Analysis

What is UCB Dividend Yield %?

UCB MEX:UCBN 85 Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus rates MEX:UCBN with a GF Score™ of 85/100 and a GF Value™ of MXN1,417.06. The stock has 2 warning signs investors should review. Among 151 Biotechnology companies, UCB ranks worse than 76.82% on this metric.

As of today (2026-06-26), the Trailing Annual Dividend Yield of UCB is 0.00%.

The historical rank and industry rank for UCB's Dividend Yield % or its related term are showing as below:

During the past 13 years, the highest Dividend Yield of UCB was 1.98%. The lowest was 0.00%. And the median was 1.51%.

MEX:UCBN's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.53
* Ranked among companies with meaningful Dividend Yield % only.

UCB's Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of UCB was 0.76. The lowest was 0.14. And the median was 0.20.

As of today (2026-06-26), the Forward Dividend Yield % of UCB is 0.00%.

UCB's Dividends per Share for the six months ended in Dec. 2025 was MXN0.00.

During the past 12 months, UCB's average Dividends Per Share Growth Rate was 2.20% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 2.30% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 2.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 2.70% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of UCB was 3.60% per year. The lowest was -10.10% per year. And the median was 2.30% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


UCB  (MEX:UCBN) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


UCB Dividend Yield % Related Terms


UCB Dividend Yield % Historical Data

* Premium members only.

The historical data trend for UCB's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UCB Dividend Yield % Chart

UCB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.35 0.00 0.00 0.00 0.00

UCB Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MEX:UCBN vs VRTX, REGN, ALNY: Dividend Yield % Comparison

For the Biotechnology subindustry, UCB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UCB Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, UCB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where UCB's Dividend Yield % falls into.


MEX:UCBN
85GF Score
UCB SA MEX:UCBN
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UCB Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

UCB Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
EUR 1.4500002026-05-052026-05-052026-05-06Cash DividendannuallyEUR:MXN 20.347251

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

UCB's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=29.50351395/1692.27
=1.74 %

Current Share Price is MXN1692.27.
UCB's Dividends per Share for the trailing twelve months (TTM) ended in Today is MXN29.50351395.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
UCB (MEX:UCBN) has a Dividend Yield % of 0.00% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on UCB and its competitors. According to the industry distribution chart, UCB ranks #116 out of 151 companies in the Biotechnology industry, placing it in the top 76.8%.
Is UCB's Dividend Yield % too high?
UCB's current Dividend Yield % is 0.00%. Based on the distribution chart, UCB ranks #116 out of 151 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, UCB has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does UCB's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, UCB ranks #116 out of 151 companies for Dividend Yield %. This places UCB in the lower half of its industry. The industry median Dividend Yield % is 1.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.53, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on UCB and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UCB's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UCB stock overvalued right now?
UCB (MEX:UCBN) has a current Dividend Yield % of 0.00%. The stock's GF Value™ is MXN1,417.06, compared to a current price of MXN1,692.27 — trading 19.4% above its estimated fair value. The current Dividend Yield % is 0.00%. UCB's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For UCB (MEX:UCBN), the current Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UCB (MEX:UCBN) Overvalued in 2026?

Based on GuruFocus' analysis, UCB stock appears to be overvalued. The current stock price of MXN1,692.27 is trading 19.4% above its estimated GF Value™ of MXN1,417.06.

Key valuation signals for MEX:UCBN:

  • Dividend Yield %: 0.00%
  • GF Value™: MXN1,417.06 vs. price of MXN1,692.27 (19.4% above fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the MEX:UCBN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


UCB Business Description

Address Allee de la Recherche, 60, Brussels, BEL, B-1070
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome), and Kygevvi (rare mitochondrial disease).
85GF Score

Get the complete analysis for MEX:UCBN

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,692.27
Price
MXN1,417.06
GF Value